Showing 2451-2460 of 2705 results for "".
- Endo’s Qwo Scores FDA Nod for Cellulite Treatmenthttps://modernaesthetics.com/news/endos-qwo-scores-fda-nod-for-cellulite-treatment/2472961/The FDA has given its nod to an entirely new way to address cellulite. Endo Aesthetic’s Qwo (collagenase clostridium histolyticum-aaes) is the first injectable treatment for moderate to severe cellulite of the buttocks in adult women. When fat in cellulite-prone areas swells and e
- Survey: Facial Plastic Surgeons Should Get Ready for the Zoom Boomhttps://modernaesthetics.com/news/survey-facial-plastic-surgeons-should-get-ready-for-the-zoom-boom/2472960/All of that Zoom has led to a boom in requests for facial plastic surgery, according to research published in The Journal of Facial Plastic Surgery and Aesthetic Medicine. The months spent on Zoom and other video conferencing services during the COVID-19 quarantine got a lot of
- CE Mark Plus Launch for System ONE-M from TOOsonix A/Shttps://modernaesthetics.com/news/ce-mark-plus-launch-for-system-one-m-from-toosonix-as/2472959/TOOsonix A/S is launching its CE-marked System ONE-M for color-independent tattoo removal, solar lentigines, spider veins, angiomas, telangiectasia and other aesthetic conditions. System ONE-M is a focused ultr
- Sciton’s New mJOULE Platform Features BBL HERO and MOXIhttps://modernaesthetics.com/news/scitons-new-mjoule-platform-features-bbl-hero-and-moxi/2472952/Sciton Inc. is rolling out their mJOULE dual-wavelength platform which includes a new fractional treatment, MOXI, and BBL HERO. MOXI delivers non-ablative laser energy to revitalize skin and BroadBand Light HERO (High Energy Rapid Output) allows practitioners to treat the entire body wi
- Obagi Rolls Out Two New Sunscreens and a Serumhttps://modernaesthetics.com/news/obagi-drops-two-new-sunscreens-and-a-serum-1/2472950/Obagi is launching two new Physical Defense Sunscreens and Daily Hydro-Drops. The new SUZANOBAGIMD Physical Defense Sunscreens, available in broad-spectrum SPF 40 and tinted SPF 50, defend against five light sources, including high energy visible light, or blue light, visible light
- ISHRS Survey: Brad Pitt, Eva Longoria Top List of Most-Desired Celebrity Lockshttps://modernaesthetics.com/news/brad-pitt-eva-longoria-top-list-of-most-desired-best-celebrity-locks/2472949/When it comes to celebrity hair, it’s Brad Pitt and Eva Longoria’s locks that are most admired, according to a
- Patients Treated with Dysport Highly Satisfied with Twice-Yearly Treatmentshttps://modernaesthetics.com/news/patients-treated-with-dysport-highly-satisfied-with-twice-yearly-treatments/2472933/Topline results of DREAM (Dysport Real-world Evaluation and Measured satisfaction study), a clinical study of Dysport (abobotulinumtoxinA) for injection, showed that 95 percent of patients treated with Dysport achieved high levels of satisfaction with two treatments per
- ISPA Consumer Survey: Med Spas May Need a Post-COVID-19 Facelift to Ease Consumer Concernshttps://modernaesthetics.com/news/ispa-consumer-survey-medspas-may-need-a-post-covid-19-facelift-to-ease-consumer-concerns/2472923/Everyone is feeling anxious about returning to public spaces including spas following the COVID-19 pandemic, according to the new ISPA Consumer Snapshot Initiative. “We know that COVID-19 has created a lot of uncertainty in many industries, including the spa industry,” says
- Lumenis Virtual Conference 2020 Starts Tomorrowhttps://modernaesthetics.com/news/lumenis-virtual-conference-2020-starts-tomorrow/2472918/Those interested in learning more about the latest laser and RF technologies, seeking treatment tips, or looking to network with other practitioners may be interested in the Lumenis Virtual Conference 2020. The conference kicks off Thursday, April 23 and Friday, April 24 with live
- Cutera Closes Public Stock Offeringhttps://modernaesthetics.com/news/cutera-closes-public-stock-offering/2472917/Cutera, Inc. has closed its previously announced underwritten public offering of 2,742,750 shares of its common stock at a public offering price of $10.50 per share, which includes the exercise in full of the underwriter’s option to purchase up to an additional 357,750 shares of its co